Search For "cipla"
Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufacture, sell
Updated : 5 years, 8 months ago IST
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" on COVID-19 patients with moderate
Read More
Cipla expands partnership with Roche Pharma to improve access for oncology
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 18 (ANI): Pharmaceutical majors Cipla and Roche Products India said on Thursday they have entered into an agreement to provide better access to innovative medicines for patients in India.
Read More
Six Indian companies applied to CDSCO for permission to manufacture, marke
Updated : 5 years, 9 months ago IST
New Delhi [India], June 14 (ANI): The Centre on Sunday said that six Indian companies -- Hetero, Cipla, BDR, Jubilant, Mylan and Dr Reddy's Labs -- have applied to Indian Drug Regulatory Agency, Central Drug Standard Control Organisation (CDSCO) for permission to manufacture and market the R
Read More
Cipla to acquire 21.85 pc stake in GoApptiv, expand reach in small towns
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 10 (ANI): Pharmaceutical major Cipla said on Wednesday it will acquire 21.85 per cent stake in GoApptiv to expand the reach of its key brands in tier three plus towns.
Read More
COVID-19: Cipla enters into licensing pact with Gilead to manufacture and
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine Remdesivir which has been issued an emergency use authorisation by t
Read More
Cipla sets up Rs 25 crore COVID-19 dedicated fund
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], April 21 (ANI): Pharmaceutical major Cipla on Tuesday announced a Rs 25 crore fund to support the government's efforts to effectively combat COVID-19 pandemic, including a voluntary donation of Rs 3 crore from its employees.
Read More
Equity indices upbeat in early trade, Cipla gains by 14 pc
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], April 9 (ANI): Equities trading firm during early hours on Thursday in line with Asian peers after Wall Street's overnight rally with investors hoping that coronavirus pandemic in the United States was nearing its peak.
Read More
Cipla receives final approval for generic version of AstraZeneca Pharmaceu
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], Mar 27 (ANI/ PRNewswire): Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla" today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Esomeprazole for Oral Suspension 10mg, 20mg and 40m
Read More
Bears hammer equities on coronavirus fears, Nifty realty down 2.5 pc
Updated : 6 years ago IST
Mumbai (Maharashtra) [India], Feb 27 (ANI): Equity benchmark indices continued to take a beating during early hours on Thursday on the back of weak global cues accentuated by coronavirus as investors sought safety in gold and bonds.
Read More
Equities remain range-bound, Cipla falls by 2.4 pc
Updated : 6 years ago IST
Mumbai (Maharashtra) [India], Feb 20 (ANI): Equity benchmark indices closed 0.37 per cent lower on Thursday as concerns over the impact of coronavirus on economic growth kept investors across the globe jittery.
Read More
Cipla arm to acquire remaining stake in Cipla Pharma Lanka
Updated : 6 years, 3 months ago IST
Mumbai (Maharashtra) [India], Nov 28 (ANI): Pharmaceutical major Cipla's arm Cipla EU Ltd has signed an agreement with CitiHealth Imports to acquire remaining 40 per cent stake in Cipla Pharma Lanka.
Read More
Cipla clocks revenue growth of 10 pc in Q2, EBITDA up by 21 pc
Updated : 6 years, 4 months ago IST
Mumbai (Maharashtra) [India], Nov 6 (ANI): Pharmaceutical major Cipla on Wednesday reported 25 per cent year-on-year increase in its consolidated net profit at Rs 471 crore for the second quarter ended September 30.
Read More